Clinical trial

Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)

NCT07671885

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-28

PhasePHASE3

Study timeline

Study start (actual)2026-01-28Date precision: day

Registry last updated2026-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Adjuvant systemic therapy based on pathological findings and ET responseDRUG

Adjuvant systemic therapy based on pathological findingsDRUG

Sponsors & collaborators

Tokyo Women's Medical Universitylead sponsor

Japan Clinical Oncology Groupcollaborator

Mapped research locations

TokyoJapan10 OsakaJapan2 HiroshimaJapan2 FukuokaJapan1 ChibaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07671885 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.